×

What are you searching for?




Healthcare

4 Min read

DAIICHI SANKYO DEVELOPING COVID-19 VACCINE CANDIDATE IN JAPAN

Published On 23 Jun 2020 11:45 AM


SHARE THIS ARTICLE  


HIGHLIGHTS

  • Daiichi Sankyo working to develop an mRNA vaccine candidate to prevent COVID-19 infection in Japan.
  • Daiichi Sankyo is helping researchers at University of Tokyo in R&D operations regarding vaccine against coronavirus.

Japanese pharmaceutical company Daiichi Sankyo working to develop a Messenger Ribonucleic Acid or Messenger RNA (mRNA) vaccine candidate to protect ag....


Tags : Daiichi Sankyo, Japan, Pharmaceuticals, coronavirus, COVID-19,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)